nodes	percent_of_prediction	percent_of_DWPC	metapath
Sofosbuvir—ABCB1—Sorafenib—thyroid cancer	0.128	0.622	CbGbCtD
Sofosbuvir—ABCB1—Doxorubicin—thyroid cancer	0.0775	0.378	CbGbCtD
Sofosbuvir—Platelet count decreased—Vandetanib—thyroid cancer	0.0285	0.0358	CcSEcCtD
Sofosbuvir—Haemoglobin decreased—Vandetanib—thyroid cancer	0.0246	0.031	CcSEcCtD
Sofosbuvir—Suicide—Sorafenib—thyroid cancer	0.022	0.0277	CcSEcCtD
Sofosbuvir—Completed suicide—Sorafenib—thyroid cancer	0.0194	0.0244	CcSEcCtD
Sofosbuvir—Blood bilirubin increased—Vandetanib—thyroid cancer	0.0179	0.0225	CcSEcCtD
Sofosbuvir—Haemoglobin decreased—Sorafenib—thyroid cancer	0.0166	0.0209	CcSEcCtD
Sofosbuvir—Dyspnoea exertional—Epirubicin—thyroid cancer	0.014	0.0176	CcSEcCtD
Sofosbuvir—Dyspnoea exertional—Doxorubicin—thyroid cancer	0.0129	0.0163	CcSEcCtD
Sofosbuvir—Gastrooesophageal reflux disease—Sorafenib—thyroid cancer	0.0126	0.0159	CcSEcCtD
Sofosbuvir—Blood bilirubin increased—Sorafenib—thyroid cancer	0.0121	0.0152	CcSEcCtD
Sofosbuvir—Dry skin—Vandetanib—thyroid cancer	0.0113	0.0142	CcSEcCtD
Sofosbuvir—Influenza like illness—Sorafenib—thyroid cancer	0.0111	0.014	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Vandetanib—thyroid cancer	0.011	0.0138	CcSEcCtD
Sofosbuvir—Neutropenia—Vandetanib—thyroid cancer	0.00993	0.0125	CcSEcCtD
Sofosbuvir—Weight decreased—Vandetanib—thyroid cancer	0.00961	0.0121	CcSEcCtD
Sofosbuvir—Infestation NOS—Vandetanib—thyroid cancer	0.00947	0.0119	CcSEcCtD
Sofosbuvir—Infestation—Vandetanib—thyroid cancer	0.00947	0.0119	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00896	0.0113	CcSEcCtD
Sofosbuvir—Eye disorder—Vandetanib—thyroid cancer	0.00795	0.01	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Vandetanib—thyroid cancer	0.00766	0.00964	CcSEcCtD
Sofosbuvir—Dry skin—Sorafenib—thyroid cancer	0.0076	0.00956	CcSEcCtD
Sofosbuvir—Alopecia—Vandetanib—thyroid cancer	0.00751	0.00946	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Sorafenib—thyroid cancer	0.00741	0.00933	CcSEcCtD
Sofosbuvir—Malnutrition—Vandetanib—thyroid cancer	0.0074	0.00932	CcSEcCtD
Sofosbuvir—Muscle spasms—Vandetanib—thyroid cancer	0.00712	0.00896	CcSEcCtD
Sofosbuvir—Vision blurred—Vandetanib—thyroid cancer	0.00698	0.00878	CcSEcCtD
Sofosbuvir—Abdominal discomfort—Sorafenib—thyroid cancer	0.00687	0.00865	CcSEcCtD
Sofosbuvir—Neutropenia—Sorafenib—thyroid cancer	0.0067	0.00843	CcSEcCtD
Sofosbuvir—Weight decreased—Sorafenib—thyroid cancer	0.00648	0.00816	CcSEcCtD
Sofosbuvir—Cough—Vandetanib—thyroid cancer	0.00646	0.00813	CcSEcCtD
Sofosbuvir—Infestation—Sorafenib—thyroid cancer	0.00639	0.00804	CcSEcCtD
Sofosbuvir—Infestation NOS—Sorafenib—thyroid cancer	0.00639	0.00804	CcSEcCtD
Sofosbuvir—Chest pain—Vandetanib—thyroid cancer	0.0063	0.00793	CcSEcCtD
Sofosbuvir—Arthralgia—Vandetanib—thyroid cancer	0.0063	0.00793	CcSEcCtD
Sofosbuvir—Anxiety—Vandetanib—thyroid cancer	0.00628	0.0079	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00626	0.00788	CcSEcCtD
Sofosbuvir—Dry mouth—Vandetanib—thyroid cancer	0.00616	0.00776	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00604	0.0076	CcSEcCtD
Sofosbuvir—Infection—Vandetanib—thyroid cancer	0.006	0.00755	CcSEcCtD
Sofosbuvir—Nervous system disorder—Vandetanib—thyroid cancer	0.00592	0.00746	CcSEcCtD
Sofosbuvir—Skin disorder—Vandetanib—thyroid cancer	0.00587	0.00738	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Sorafenib—thyroid cancer	0.00564	0.00709	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.0055	0.00693	CcSEcCtD
Sofosbuvir—Insomnia—Vandetanib—thyroid cancer	0.00546	0.00688	CcSEcCtD
Sofosbuvir—Dyspnoea—Vandetanib—thyroid cancer	0.00539	0.00678	CcSEcCtD
Sofosbuvir—Dyspepsia—Vandetanib—thyroid cancer	0.00532	0.00669	CcSEcCtD
Sofosbuvir—Decreased appetite—Vandetanib—thyroid cancer	0.00525	0.00661	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00522	0.00656	CcSEcCtD
Sofosbuvir—Fatigue—Vandetanib—thyroid cancer	0.00521	0.00655	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Sorafenib—thyroid cancer	0.00517	0.00651	CcSEcCtD
Sofosbuvir—Pain—Vandetanib—thyroid cancer	0.00517	0.0065	CcSEcCtD
Sofosbuvir—Constipation—Vandetanib—thyroid cancer	0.00517	0.0065	CcSEcCtD
Sofosbuvir—Alopecia—Sorafenib—thyroid cancer	0.00507	0.00638	CcSEcCtD
Sofosbuvir—Malnutrition—Sorafenib—thyroid cancer	0.00499	0.00628	CcSEcCtD
Sofosbuvir—Muscle spasms—Sorafenib—thyroid cancer	0.0048	0.00604	CcSEcCtD
Sofosbuvir—Body temperature increased—Vandetanib—thyroid cancer	0.00478	0.00601	CcSEcCtD
Sofosbuvir—Anaemia—Sorafenib—thyroid cancer	0.00462	0.00581	CcSEcCtD
Sofosbuvir—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00446	0.00562	CcSEcCtD
Sofosbuvir—Cough—Sorafenib—thyroid cancer	0.00436	0.00548	CcSEcCtD
Sofosbuvir—Asthenia—Vandetanib—thyroid cancer	0.00433	0.00545	CcSEcCtD
Sofosbuvir—Pruritus—Vandetanib—thyroid cancer	0.00427	0.00538	CcSEcCtD
Sofosbuvir—Arthralgia—Sorafenib—thyroid cancer	0.00425	0.00535	CcSEcCtD
Sofosbuvir—Myalgia—Sorafenib—thyroid cancer	0.00425	0.00535	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00422	0.00531	CcSEcCtD
Sofosbuvir—Dry mouth—Sorafenib—thyroid cancer	0.00416	0.00523	CcSEcCtD
Sofosbuvir—Diarrhoea—Vandetanib—thyroid cancer	0.00413	0.0052	CcSEcCtD
Sofosbuvir—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00413	0.0052	CcSEcCtD
Sofosbuvir—Influenza like illness—Epirubicin—thyroid cancer	0.0041	0.00516	CcSEcCtD
Sofosbuvir—Infection—Sorafenib—thyroid cancer	0.00405	0.00509	CcSEcCtD
Sofosbuvir—Nervous system disorder—Sorafenib—thyroid cancer	0.004	0.00503	CcSEcCtD
Sofosbuvir—Dizziness—Vandetanib—thyroid cancer	0.004	0.00503	CcSEcCtD
Sofosbuvir—Skin disorder—Sorafenib—thyroid cancer	0.00396	0.00498	CcSEcCtD
Sofosbuvir—Vomiting—Vandetanib—thyroid cancer	0.00384	0.00483	CcSEcCtD
Sofosbuvir—Rash—Vandetanib—thyroid cancer	0.00381	0.00479	CcSEcCtD
Sofosbuvir—Dermatitis—Vandetanib—thyroid cancer	0.00381	0.00479	CcSEcCtD
Sofosbuvir—Influenza like illness—Doxorubicin—thyroid cancer	0.00379	0.00477	CcSEcCtD
Sofosbuvir—Headache—Vandetanib—thyroid cancer	0.00378	0.00476	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00371	0.00467	CcSEcCtD
Sofosbuvir—Dyspnoea—Sorafenib—thyroid cancer	0.00363	0.00457	CcSEcCtD
Sofosbuvir—Nausea—Vandetanib—thyroid cancer	0.00359	0.00452	CcSEcCtD
Sofosbuvir—Dyspepsia—Sorafenib—thyroid cancer	0.00359	0.00451	CcSEcCtD
Sofosbuvir—Decreased appetite—Sorafenib—thyroid cancer	0.00354	0.00446	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00352	0.00443	CcSEcCtD
Sofosbuvir—Fatigue—Sorafenib—thyroid cancer	0.00351	0.00442	CcSEcCtD
Sofosbuvir—Constipation—Sorafenib—thyroid cancer	0.00348	0.00439	CcSEcCtD
Sofosbuvir—Pain—Sorafenib—thyroid cancer	0.00348	0.00439	CcSEcCtD
Sofosbuvir—Body temperature increased—Sorafenib—thyroid cancer	0.00322	0.00405	CcSEcCtD
Sofosbuvir—Migraine—Epirubicin—thyroid cancer	0.00302	0.0038	CcSEcCtD
Sofosbuvir—Asthenia—Sorafenib—thyroid cancer	0.00292	0.00368	CcSEcCtD
Sofosbuvir—Pruritus—Sorafenib—thyroid cancer	0.00288	0.00363	CcSEcCtD
Sofosbuvir—Dry skin—Epirubicin—thyroid cancer	0.00281	0.00353	CcSEcCtD
Sofosbuvir—Migraine—Doxorubicin—thyroid cancer	0.00279	0.00351	CcSEcCtD
Sofosbuvir—Diarrhoea—Sorafenib—thyroid cancer	0.00279	0.00351	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Epirubicin—thyroid cancer	0.00274	0.00345	CcSEcCtD
Sofosbuvir—Dizziness—Sorafenib—thyroid cancer	0.00269	0.00339	CcSEcCtD
Sofosbuvir—Dry skin—Doxorubicin—thyroid cancer	0.0026	0.00327	CcSEcCtD
Sofosbuvir—Vomiting—Sorafenib—thyroid cancer	0.00259	0.00326	CcSEcCtD
Sofosbuvir—Rash—Sorafenib—thyroid cancer	0.00257	0.00323	CcSEcCtD
Sofosbuvir—Dermatitis—Sorafenib—thyroid cancer	0.00257	0.00323	CcSEcCtD
Sofosbuvir—Headache—Sorafenib—thyroid cancer	0.00255	0.00321	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00254	0.00319	CcSEcCtD
Sofosbuvir—Pancytopenia—Epirubicin—thyroid cancer	0.00252	0.00317	CcSEcCtD
Sofosbuvir—Neutropenia—Epirubicin—thyroid cancer	0.00248	0.00312	CcSEcCtD
Sofosbuvir—Nausea—Sorafenib—thyroid cancer	0.00242	0.00305	CcSEcCtD
Sofosbuvir—Weight decreased—Epirubicin—thyroid cancer	0.0024	0.00302	CcSEcCtD
Sofosbuvir—Infestation—Epirubicin—thyroid cancer	0.00236	0.00297	CcSEcCtD
Sofosbuvir—Infestation NOS—Epirubicin—thyroid cancer	0.00236	0.00297	CcSEcCtD
Sofosbuvir—Pancytopenia—Doxorubicin—thyroid cancer	0.00233	0.00293	CcSEcCtD
Sofosbuvir—Neutropenia—Doxorubicin—thyroid cancer	0.00229	0.00288	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00223	0.00281	CcSEcCtD
Sofosbuvir—Weight decreased—Doxorubicin—thyroid cancer	0.00222	0.00279	CcSEcCtD
Sofosbuvir—Infestation NOS—Doxorubicin—thyroid cancer	0.00219	0.00275	CcSEcCtD
Sofosbuvir—Infestation—Doxorubicin—thyroid cancer	0.00219	0.00275	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Epirubicin—thyroid cancer	0.00208	0.00262	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00207	0.0026	CcSEcCtD
Sofosbuvir—Eye disorder—Epirubicin—thyroid cancer	0.00198	0.00249	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00193	0.00243	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Epirubicin—thyroid cancer	0.00191	0.0024	CcSEcCtD
Sofosbuvir—Chills—Epirubicin—thyroid cancer	0.0019	0.00239	CcSEcCtD
Sofosbuvir—Alopecia—Epirubicin—thyroid cancer	0.00187	0.00236	CcSEcCtD
Sofosbuvir—Malnutrition—Epirubicin—thyroid cancer	0.00185	0.00232	CcSEcCtD
Sofosbuvir—Eye disorder—Doxorubicin—thyroid cancer	0.00183	0.00231	CcSEcCtD
Sofosbuvir—Back pain—Epirubicin—thyroid cancer	0.00179	0.00225	CcSEcCtD
Sofosbuvir—Muscle spasms—Epirubicin—thyroid cancer	0.00177	0.00223	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00177	0.00222	CcSEcCtD
Sofosbuvir—Chills—Doxorubicin—thyroid cancer	0.00176	0.00221	CcSEcCtD
Sofosbuvir—Vision blurred—Epirubicin—thyroid cancer	0.00174	0.00219	CcSEcCtD
Sofosbuvir—Alopecia—Doxorubicin—thyroid cancer	0.00173	0.00218	CcSEcCtD
Sofosbuvir—Malnutrition—Doxorubicin—thyroid cancer	0.00171	0.00215	CcSEcCtD
Sofosbuvir—Anaemia—Epirubicin—thyroid cancer	0.00171	0.00215	CcSEcCtD
Sofosbuvir—Agitation—Epirubicin—thyroid cancer	0.0017	0.00213	CcSEcCtD
Sofosbuvir—Back pain—Doxorubicin—thyroid cancer	0.00165	0.00208	CcSEcCtD
Sofosbuvir—Muscle spasms—Doxorubicin—thyroid cancer	0.00164	0.00207	CcSEcCtD
Sofosbuvir—Cough—Epirubicin—thyroid cancer	0.00161	0.00203	CcSEcCtD
Sofosbuvir—Vision blurred—Doxorubicin—thyroid cancer	0.00161	0.00203	CcSEcCtD
Sofosbuvir—Anaemia—Doxorubicin—thyroid cancer	0.00158	0.00199	CcSEcCtD
Sofosbuvir—Arthralgia—Epirubicin—thyroid cancer	0.00157	0.00198	CcSEcCtD
Sofosbuvir—Myalgia—Epirubicin—thyroid cancer	0.00157	0.00198	CcSEcCtD
Sofosbuvir—Chest pain—Epirubicin—thyroid cancer	0.00157	0.00198	CcSEcCtD
Sofosbuvir—Agitation—Doxorubicin—thyroid cancer	0.00157	0.00197	CcSEcCtD
Sofosbuvir—Anxiety—Epirubicin—thyroid cancer	0.00157	0.00197	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00156	0.00196	CcSEcCtD
Sofosbuvir—Dry mouth—Epirubicin—thyroid cancer	0.00154	0.00193	CcSEcCtD
Sofosbuvir—Infection—Epirubicin—thyroid cancer	0.0015	0.00188	CcSEcCtD
Sofosbuvir—Cough—Doxorubicin—thyroid cancer	0.00149	0.00188	CcSEcCtD
Sofosbuvir—Nervous system disorder—Epirubicin—thyroid cancer	0.00148	0.00186	CcSEcCtD
Sofosbuvir—Skin disorder—Epirubicin—thyroid cancer	0.00146	0.00184	CcSEcCtD
Sofosbuvir—Arthralgia—Doxorubicin—thyroid cancer	0.00145	0.00183	CcSEcCtD
Sofosbuvir—Chest pain—Doxorubicin—thyroid cancer	0.00145	0.00183	CcSEcCtD
Sofosbuvir—Myalgia—Doxorubicin—thyroid cancer	0.00145	0.00183	CcSEcCtD
Sofosbuvir—Anxiety—Doxorubicin—thyroid cancer	0.00145	0.00182	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00144	0.00182	CcSEcCtD
Sofosbuvir—Dry mouth—Doxorubicin—thyroid cancer	0.00142	0.00179	CcSEcCtD
Sofosbuvir—Infection—Doxorubicin—thyroid cancer	0.00138	0.00174	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00137	0.00173	CcSEcCtD
Sofosbuvir—Nervous system disorder—Doxorubicin—thyroid cancer	0.00137	0.00172	CcSEcCtD
Sofosbuvir—Insomnia—Epirubicin—thyroid cancer	0.00136	0.00171	CcSEcCtD
Sofosbuvir—Skin disorder—Doxorubicin—thyroid cancer	0.00135	0.0017	CcSEcCtD
Sofosbuvir—Dyspnoea—Epirubicin—thyroid cancer	0.00134	0.00169	CcSEcCtD
Sofosbuvir—Dyspepsia—Epirubicin—thyroid cancer	0.00133	0.00167	CcSEcCtD
Sofosbuvir—Decreased appetite—Epirubicin—thyroid cancer	0.00131	0.00165	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.0013	0.00164	CcSEcCtD
Sofosbuvir—Fatigue—Epirubicin—thyroid cancer	0.0013	0.00163	CcSEcCtD
Sofosbuvir—Constipation—Epirubicin—thyroid cancer	0.00129	0.00162	CcSEcCtD
Sofosbuvir—Pain—Epirubicin—thyroid cancer	0.00129	0.00162	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00127	0.0016	CcSEcCtD
Sofosbuvir—Insomnia—Doxorubicin—thyroid cancer	0.00126	0.00159	CcSEcCtD
Sofosbuvir—Dyspnoea—Doxorubicin—thyroid cancer	0.00124	0.00156	CcSEcCtD
Sofosbuvir—Dyspepsia—Doxorubicin—thyroid cancer	0.00123	0.00154	CcSEcCtD
Sofosbuvir—Decreased appetite—Doxorubicin—thyroid cancer	0.00121	0.00152	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.0012	0.00151	CcSEcCtD
Sofosbuvir—Fatigue—Doxorubicin—thyroid cancer	0.0012	0.00151	CcSEcCtD
Sofosbuvir—Pain—Doxorubicin—thyroid cancer	0.00119	0.0015	CcSEcCtD
Sofosbuvir—Constipation—Doxorubicin—thyroid cancer	0.00119	0.0015	CcSEcCtD
Sofosbuvir—Body temperature increased—Epirubicin—thyroid cancer	0.00119	0.0015	CcSEcCtD
Sofosbuvir—Body temperature increased—Doxorubicin—thyroid cancer	0.0011	0.00139	CcSEcCtD
Sofosbuvir—Asthenia—Epirubicin—thyroid cancer	0.00108	0.00136	CcSEcCtD
Sofosbuvir—Pruritus—Epirubicin—thyroid cancer	0.00107	0.00134	CcSEcCtD
Sofosbuvir—Diarrhoea—Epirubicin—thyroid cancer	0.00103	0.0013	CcSEcCtD
Sofosbuvir—Asthenia—Doxorubicin—thyroid cancer	0.001	0.00126	CcSEcCtD
Sofosbuvir—Dizziness—Epirubicin—thyroid cancer	0.000996	0.00125	CcSEcCtD
Sofosbuvir—Pruritus—Doxorubicin—thyroid cancer	0.000986	0.00124	CcSEcCtD
Sofosbuvir—Vomiting—Epirubicin—thyroid cancer	0.000958	0.00121	CcSEcCtD
Sofosbuvir—Diarrhoea—Doxorubicin—thyroid cancer	0.000953	0.0012	CcSEcCtD
Sofosbuvir—Rash—Epirubicin—thyroid cancer	0.00095	0.0012	CcSEcCtD
Sofosbuvir—Dermatitis—Epirubicin—thyroid cancer	0.000949	0.00119	CcSEcCtD
Sofosbuvir—Headache—Epirubicin—thyroid cancer	0.000944	0.00119	CcSEcCtD
Sofosbuvir—Dizziness—Doxorubicin—thyroid cancer	0.000922	0.00116	CcSEcCtD
Sofosbuvir—Nausea—Epirubicin—thyroid cancer	0.000895	0.00113	CcSEcCtD
Sofosbuvir—Vomiting—Doxorubicin—thyroid cancer	0.000886	0.00112	CcSEcCtD
Sofosbuvir—Rash—Doxorubicin—thyroid cancer	0.000879	0.00111	CcSEcCtD
Sofosbuvir—Dermatitis—Doxorubicin—thyroid cancer	0.000878	0.0011	CcSEcCtD
Sofosbuvir—Headache—Doxorubicin—thyroid cancer	0.000873	0.0011	CcSEcCtD
Sofosbuvir—Nausea—Doxorubicin—thyroid cancer	0.000828	0.00104	CcSEcCtD
